Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk

Alice W Lee¹, Roberta B Ness, Lynda D Roman+30

• ¹Departments of Preventive Medicine and Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California; the University of Texas School of Public Health, Houston, Texas; the Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, and the Harvard T. H. Chan School of Public Health, Boston, Massachusetts; the Department of Public Health Sciences, the University of Virginia, Charlottesville, Virginia; the Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, and the University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; the Department of Epidemiology, the Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom; the Center for Cancer Prevention and Translational Genomics and Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, the Department of Biomedical Sciences, and the Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California; the Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut; the Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, the Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, and the Women's Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; the Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; the Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; the Department of Epidemiology, University of Washington, and the Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; the Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, and the Molecular Unit, Department of Pathology, Herley Hospital, and the Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; the Cancer Epidemiology Program, University of Hawaii Cancer Center, and the Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; and the Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.